Name: UMIN ID:
Unique ID issued by UMIN | C000000150 |
---|---|
Receipt number | R000000216 |
Scientific Title | A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer |
Date of disclosure of the study information | 2005/09/09 |
Last modified on | 2015/08/31 15:51:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/09 17:03:29 | ||
2 | Update | 2005/09/12 16:42:01 | Key inclusion criteria |
|
3 | Update | 2008/05/28 10:39:27 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Organization Division name Address TEL Institute Institute Organization Organization Category of Funding Organization Organization1 Email1 |
|
4 | Update | 2008/12/09 11:23:36 | Last follow-up date |
|
5 | Update | 2009/09/09 09:09:42 | Recruitment status |
|
6 | Update | 2010/08/30 16:54:44 | Organization Organization Name of person sending information Organization Division name Address Organization1 Address1 Tel1 Email1 |
|
7 | Update | 2010/08/30 17:07:52 | Narrative objectives1 Primary outcomes Primary outcomes |
|
8 | Update | 2011/04/11 09:19:31 | Email1 |
|
9 | Update | 2014/06/10 10:08:26 | Recruitment status Publication of results |
|
10 | Update | 2015/08/31 15:51:13 | URL related to results and publications |